MYC and breast carcinoma: Based on the Au-TIOP NPs smaller than 10 nm that could enter the nucleus, the nanoparticle-conjugated TFOs were more effective at reducing c-myc RNA and c-myc protein in breast cancer cells than free TFOs (Huo et al., 2014).